These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9135550)

  • 41. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
    Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
    J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
    Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Class switch recombination and somatic hypermutation of virus-neutralizing antibodies are not essential for control of friend retrovirus infection.
    Kato M; Tsuji-Kawahara S; Kawasaki Y; Kinoshita S; Chikaishi T; Takamura S; Fujisawa M; Kawada A; Miyazawa M
    J Virol; 2015 Jan; 89(2):1468-73. PubMed ID: 25378499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukaemia virus).
    Strestik BD; Olbrich ARM; Hasenkrug KJ; Dittmer U
    J Gen Virol; 2001 Jun; 82(Pt 6):1349-1354. PubMed ID: 11369878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice.
    Robertson MN; Spangrude GJ; Hasenkrug K; Perry L; Nishio J; Wehrly K; Chesebro B
    J Virol; 1992 Jun; 66(6):3271-7. PubMed ID: 1374804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retroviral immunology: lessons from a mouse model.
    Myers L; Hasenkrug KJ
    Immunol Res; 2009; 43(1-3):160-6. PubMed ID: 18830572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
    Sugahara D; Tsuji-Kawahara S; Miyazawa M
    J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to Friend murine leukemia virus infection conferred by the Fv-4 gene is recessive but appears dominant from the effect of the immune system.
    Zhang F; Ya LT; Iwatani Y; Higo K; Suzuki Y; Tanaka M; Nakahara T; Ono T; Sakai H; Kuribayashi K; Ishimoto A
    J Virol; 2000 Jul; 74(13):6193-7. PubMed ID: 10846105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3.
    Gibbert K; Francois S; Sigmund AM; Harper MS; Barrett BS; Kirchning CJ; Lu M; Santiago ML; Dittmer U
    Retrovirology; 2014 Dec; 11():126. PubMed ID: 25539593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody.
    Nasser R; Pelegrin M; Michaud HA; Plays M; Piechaczyk M; Gros L
    J Virol; 2010 Oct; 84(19):10169-81. PubMed ID: 20610721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A shift in the requirement for CD4+ T cells in the generation of AKR/Gross MuLV-specific CTL in AKR.H-2b:Fv-1b mice occurs prior to the onset of age-dependent CTL nonresponsiveness.
    Smith PM; Rich RF; Green WR
    Cell Immunol; 1997 Feb; 175(2):189-98. PubMed ID: 9023425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.
    Genovesi EV; Collins JJ
    J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV.
    Coppola MA; Green WR; Rich RF
    Viral Immunol; 1996; 9(2):107-19. PubMed ID: 8822627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New cell surface gp70 related to Friend mink cell focus-inducing virus is expressed on Friend virus-induced erythroleukemic spleen cells after elimination of ecotropic Friend virus gp70 in Rfv-3r/s mice.
    Britt WJ; Collins JK; Chesebro B
    J Exp Med; 1981 Sep; 154(3):868-82. PubMed ID: 6974219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detailed mapping of the Rfv-1 gene that influences spontaneous recovery from Friend retrovirus-induced leukaemia.
    Miyazawa M; Nishio J; Wehrly K; Jay G; Melvold RW; Chesebro B
    Eur J Immunogenet; 1992 Jun; 19(3):159-64. PubMed ID: 1627536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues.
    Hu J; Kindsvogel W; Busby S; Bailey MC; Shi YY; Greenberg PD
    J Exp Med; 1993 Jun; 177(6):1681-90. PubMed ID: 8496686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a viral antigen recognized by H-2-restricted cytolytic T lymphocytes on a murine leukemia virus-induced tumor.
    Plata F; Kalil J; Zilber MT; Fellous M; Lévy D
    J Immunol; 1983 Nov; 131(5):2551-6. PubMed ID: 6605389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.